Kaiser Affiliates Agree to $556M Medicare Advantage Fraud Settlement in US

Key Takeaways: 

• Kaiser Permanente health plan affiliates will pay $556 million to resolve US Justice Department allegations of Medicare Advantage upcoding from 2009 to 2018.
• The US Department of Justice (DOJ) alleged that physicians in California and Colorado were pressured to add invalid diagnoses to inflate risk scores and increase federal reimbursement.
• Kaiser admitted no wrongdoing, while whistleblowers under the False Claims Act will receive $95 million from the settlement.

Kaiser Permanente health plan affiliates have agreed to a $556 million settlement with the DOJ to resolve allegations of Medicare Advantage fraud. According to the DOJ, the plans submitted invalid diagnostic codes to increase risk-adjusted payments from Medicare. The case represents the largest settlement to date tied to alleged Medicare Advantage upcoding misconduct.

Main News

The DOJ alleged that from 2009 to 2018, Kaiser affiliates engaged in a “widespread coordinated scheme” to inflate the documented illness burden of Medicare Advantage enrollees in California and Colorado. Prosecutors claimed physicians were encouraged to add “thousands upon thousands” of unsupported diagnoses to medical records, sometimes months after patient visits, to boost Medicare reimbursement.

Under Medicare Advantage, insurers receive higher payments for sicker patients through risk adjustment based largely on diagnostic codes. The DOJ asserted that Kaiser linked employee and facility bonuses to coding intensity, incentivizing clinicians to document conditions that were unrelated to patient encounters. In some cases, the complaint alleged that physicians were warned that failing to add more codes could harm Kaiser and their own financial standing.

The settlement covers Kaiser Foundation Health Plan, Kaiser Foundation Health Plan of Colorado, The Permanente Medical Group, Southern California Permanente Medical Group, and Colorado Permanente Medical Group. Kaiser denied wrongdoing and said it chose to settle to avoid prolonged litigation. In a statement, the organization noted that other major insurers have faced “similar government scrutiny,” reflecting what it described as industrywide compliance challenges.

The case originated from a whistleblower lawsuit filed under the False Claims Act by former Kaiser employees Ronda Osinek and Dr James Taylor. Osinek reported that more than half of physicians told her they felt pressured to upcode, while Taylor previously served as medical director for revenue cycle and claims at The Permanente Medical Group. The 2 whistleblowers will receive $95 million from the settlement.

Clinical Implications

For clinicians practicing in Medicare Advantage settings, the settlement underscores heightened regulatory scrutiny of diagnostic coding and documentation practices. Risk adjustment is intended to reflect true patient complexity, but aggressive coding strategies can expose organizations and providers to legal and financial risk.

Physicians may face increasing pressure to ensure diagnostic accuracy, appropriate documentation, and alignment between clinical assessments and coded conditions. The case also highlights the importance of internal compliance systems and clinician education to prevent improper coding practices. As the Centers for Medicare and Medicaid Services (CMS) expands audits of Medicare Advantage plans nationwide, providers may see closer review of diagnosis capture, retrospective chart reviews, and financial incentives tied to coding.

More broadly, the settlement reflects ongoing federal concern that upcoding contributes to higher Medicare spending. The Medicare Payment Advisory Commission has estimated that Medicare Advantage costs the government substantially more than traditional Medicare, in part due to risk score inflation.

The DOJ alleged that Kaiser affiliates “ignored numerous red flags and internal warnings,” including concerns raised by their own physicians, when pursuing higher Medicare Advantage payments.

Conclusion

The $556 million Kaiser settlement marks a significant enforcement action in the US government’s ongoing scrutiny of Medicare Advantage risk adjustment. As enrollment in Medicare Advantage continues to grow, the case signals sustained regulatory focus on diagnostic coding integrity and compliance across health plans and provider organizations.

Reference

Halleman S. Kaiser affiliates to pay $556M to resolve Medicare Advantage fraud allegations. Healthcare Dive. Published January 15, 2026. Accessed February 9, 2026. https://www.healthcaredive.com/news/kaiser-affiliates-to-pay-556m-to-resolve-medicare-advantage-fraud-allegati/809716/